Abstract
This report analyzes the worldwide markets for Molecular Diagnostics in
Millions of US$. The specific product segments analyzed are Infectious Disease
Testing, Pharmacogenomics, and Cancer Screening. The report provides separate
comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and
Rest of World. Annual forecasts are provided for each region for the period of
2000 through 2015. The report profiles 103 companies including many key and
niche players worldwide such as Abbott Laboratories, Abbott Molecular, Applera
Corporation, Celera, Biomérieux, CytoCore Inc., GE Healthcare, Gen-Probe Inc.,
Genzyme Corporation, Genzyme Genetics, MiraiBio, Inc., Nanogen, Novartis
Vaccines & Diagnostics, Inc., QIAGEN N. V, Digene Corporation, Quest
Diagnostics Incorporated, Roche Diagnostics, Siemens Healthcare Diagnostics,
and Tecan Group Ltd. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research
and reported select online sources.
View Cart
